GALT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GALT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Galectin Therapeutics's intangible assets for the quarter that ended in Sep. 2023 was $0.00 Mil.
The historical data trend for Galectin Therapeutics's Intangible Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.
Galectin Therapeutics (NAS:GALT) Intangible Assets Explanation
If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.
The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.
Some intangibles are amortized. Amortization is the depreciation of intangible assets.
Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.
Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.
If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.
Intangibles acquired are on balance sheet at fair value.
Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.
One of the reasons competitive advantage power can remain hidden for so long.
Be Aware
Companies may change the way intangible assets are amortized, and this will affect their reported earnings.
Thank you for viewing the detailed overview of Galectin Therapeutics's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Kary Eldred | director | 2121 RINGWOOD AVENUE, SAN JOSE CA 95131 |
Kevin D Freeman | director | 712 LAKEWAY DRIVE, KELLER TX 76248 |
Zordani Richard A. Jr. | director | 467 N. COUNTRY RIDGE CT., LAKE ZURICH IL 60047 |
10x Fund, L.p. | 10 percent owner | 1099 FOREST LAKE TERRACE, NICEVILLE FL 32578 |
Elissa J. Schwartz | director | 235 SW CHURCH ST., PULLMAN WA 99163 |
Gilbert F Amelio | director | 5835 STRASBOURG COURT, ---, RENO NV 89511 |
Richard E Uihlein | director, 10 percent owner | 12575 ULINE DRIVE, PLEASANT PRAIRIE WI 53158 |
Pol F Boudes | officer: Chief Medical Officer | C/O CYMABAY THERAPEUTICS, INC., 7575 GATEWAY BLVD., SUITE 110, NEWARK CA 94560 |
Joel Lewis | director | 12575 ULINE DRIVE, PLEASANT PRAIRIE WI 53158 |
Gilbert S Omenn | director | AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799 |
Harold H. Shlevin | director, officer: Chief Executive Officer | C/O GALECTIN THERAPEUTICS, INC., 4690 PEACHTREE INDUSTRIAL BLVD, STE. 240, NORCROSS GA 30071 |
Jack W Callicutt | officer: Chief Financial Officer | 75 FIFTH STREET NW STE. 313, ATLANTA GA 30308 |
Marc Rubin | director | C/O TITAN PHARMACEUTICALS, INC., 400 OYSTER POINT BLVD., STE 505, SAN FRANCISCO CA 94080 |
James C Czirr | director | 4908 SOUTH ASHTON COURT, SPOKANE WA 99223 |
Peter G Traber | director, officer: President and CEO | 430 THAMER LANE, HOUSTON TX 77025 |
From GuruFocus
By sperokesalga 05-15-2023
By PurpleRose 07-11-2022
By Stock market mentor 01-24-2023
By PurpleRose 08-15-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.